Journals / Turkish Journal of Chemistry / 2022 / Cilt: 46 - Sayı: 3

Electroanalytical investigation and voltammetric quantification of antiviral drug favipiravir in the pharmaceutical formulation and urine sample using a glassy carbon electrode in anionic surfactant media

Pages
869–880
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The proposed approach was used successfully to determine FAV in pharmaceutical formulations and model human urine samples.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This work describes the electrochemical investigation of a promising antiviral agent, favipiravir (FAV) utilizing a nonmodified glassy carbon (GC) electrode, along with a unique voltammetric approach that can determine FAV with a good degree of accuracy, speed, and cost-effectiveness.
📊
Key Findings & Data:Using cyclic voltammetry, the compound demonstrated a single well-defined and an irreversible oxidation peak at approximately +1.12 V (vs.
💡
Conclusion & Impact:The proposed approach was used successfully to determine FAV in pharmaceutical formulations and model human urine samples.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

This work describes the electrochemical investigation of a promising antiviral agent, favipiravir (FAV) utilizing a nonmodified glassy carbon (GC) electrode, along with a unique voltammetric approach that can determine FAV with a good degree of accuracy, speed, and cost-effectiveness. Using cyclic voltammetry, the compound demonstrated a single well-defined and an irreversible oxidation peak at approximately +1.12 V (vs. Ag/AgCl) in Britton–Robinson (BR) buffer at pH 10.0. The synergistic effect of anionic surfactant, sodium dodecyl sulfate (SDS) on the adsorption ability of GC electrode remarkably increased the sensitivity of the stripping voltammetric measurements of FAV. Employing square-wave adsorptive stripping voltammetry at +1.17 V (vs. Ag/AgCl) (after 60 s accumulation at open-circuit condition) in BR buffer (pH 10.0) containing 3 × 10–4 M SDS, the linear relationship is found for FAV quantification in the concentration from 1.0 to 100.0 $μg mL^{–1} (6.4 × 10^{–6}–6.4 × 10^{–}4 M)$ with a detection limit of 0.26 $μg mL^{–1} (1.7 × 10^{–6} M)$. The proposed approach was used successfully to determine FAV in pharmaceutical formulations and model human urine samples.

🔖

Cite This Article

ŞENTÜRK, Z., AKÇA, Z., YARDIM, Y., ÖZOK, H. İ. (2022). Electroanalytical investigation and voltammetric quantification of antiviral drug favipiravir in the pharmaceutical formulation and urine sample using a glassy carbon electrode in anionic surfactant media. Turkish Journal of Chemistry, Cilt: 46 - Sayı: 3, 869–880. https://ajindex.com/articles/601339

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Coomes EA, Haghbayan H. Favipiravir, an antiviral for COVID-19?. Journal of Antimicrobial Chemotherapy 2020; 75 (7): 2013- 2014
  2. Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Research 2013; 100 (2): 446-454
  3. Goldhill DH, Te Velthuis AJ, Fletcher RA, Langat P, Zambon M et al. The mechanism of resistance to favipiravir in influenza. Proceedings of the National Academy of Sciences 2018; 115 (45): 11613-11618
  4. Bulduk İA. Comparison of HPLC and UV spectrophotometric methods for quantification of favipiravir in pharmaceutical formulations. Iranian Journal of Pharmaceutical Research 2021; 20 (3): 57-65
  5. Megahed SM, Habib AA, Hammad SF, Kamal AH. Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2021; 249: 119241
  6. Onmaz DE, Abusoglu S, Onmaz M, Yerlikaya FH, Unlu A. Development and validation of a sensitive, fast and simple LC-MS/MS method for the quantitation of favipiravir in human serum. Journal of Chromatography B 2021; 1176: 122768
  7. Mikhail IE, Elmansi H, Belal F, Ibrahim AE. Green micellar solvent-free HPLC and spectrofluorimetric determination of favipiravir as one of COVID-19 antiviral regimens. Microchemical Journal 2021; 165: 106189
  8. Nadendla R, Abhinandana PA. Validated high performance liquid chromatographic method for the quantification of favipiravir by PDA detector. International Journal of Life science and Pharma Research 2021; 11 (2): P181-188
  9. Curley P, Neary M, Arshad U, Tatham L, Pertinez H et al. Development of a highly sensitive bioanalytical assay for the quantification of favipiravir. bioRxiv doi: 10.1101/2021.02.03.429628 10. Hailat M, Al-Ani I, Hamad M, Zakareia Z, Abu Dayyih W. Development and validation of a method for quantification of favipiravir as COVID-19 management in spiked human plasma. Molecules 2021; 26 (13): 3789
  10. Allahverdiyeva S, Yunusoğlu O, Yardım Y, Şentürk Z. First electrochemical evaluation of favipiravir used as an antiviral option in the treatment of COVID-19: A study of its enhanced voltammetric determination in cationic surfactant media using a boron-doped diamond electrode. Analytica Chimica Acta 2021; 1159: 338418
  11. Mohamed MA, Eldin GM, Ismail SM, Zine N, Elaissari A et al. Innovativ